Medication info
Glicetam Tablets

Glicetam Tablets

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›500mg / 1 tabletGlimepiride›2mg / 1 tablet
Manufacturer / importer
Seongwon Adcock Pharmaceutical Co., Ltd.
Appearance
White oblong film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201801420 · Approved 2018.03.30 · Insurance code 664901570

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
This medicine is administered 1~2 times daily immediately before or with meals. The dose may be adjusted taking into account each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, which may be adjusted according to the patient's current medicines and blood glucose levels. In clinical trials, the initial daily dose of this medicine was glimepiride/metformin hydrochloride 2mg/500mg; based on blood glucose monitoring, the dose was gradually increased up to glimepiride/metformin hydrochloride 8mg/2000mg. With glimepiride as a single agent, there is generally little additional effect at doses above 4mg per day, although some patients showed improved metabolic control when the dose was increased to 6mg (or 8mg). When used as a replacement for combination therapy, administer according to the dosage and administration of glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than a single dose at the next scheduled administration.

Ingredients

Manufacturer
Seongwon Adcock Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medication assists in controlling blood glucose levels in patients with type 2 diabetes, serving as an adjunct to diet and exercise. Glimepiride and metformin work together to effectively lower blood glucose levels, making it suitable for those who require blood glucose management.

How to take

Adult dose

This medicine is administered 1~2 times daily immediately before or with meals. The dose may be adjusted taking into account each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, which may be adjusted according to the patient's current medicines and blood glucose levels. In clinical trials, the initial daily dose of this medicine was glimepiride/metformin hydrochloride 2mg/500mg; based on blood glucose monitoring, the dose was gradually increased up to glimepiride/metformin hydrochloride 8mg/2000mg. With glimepiride as a single agent, there is generally little additional effect at doses above 4mg per day, although some patients showed improved metabolic control when the dose was increased to 6mg (or 8mg). When used as a replacement for combination therapy, administer according to the dosage and administration of glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than a single dose at the next scheduled administration.

Precautions

This medication may cause severe lactic acidosis or hypoglycemia; therefore, caution is needed. In particular, if kidney function deteriorates rapidly, metformin may accumulate in the body and increase the risk of lactic acidosis, so patients with poor kidney function should avoid taking it. In cases of dehydration, severe diarrhea, vomiting, or fever, the use of this medication should be temporarily discontinued, and a doctor must be consulted. Additionally, certain medications may affect kidney function when used concurrently, so healthcare providers should be informed of any other medications being taken. Patients at risk for cardiovascular disease should be particularly cautious as this medication may increase cardiovascular mortality. This medication should not be administered to patients with insulin-dependent diabetes, acute metabolic acidosis, severe liver dysfunction, severe kidney impairment, or to pregnant or nursing women. During treatment, there is a risk of hypoglycemia, so patients should avoid skipping meals, excessive exercise, and alcohol consumption, and should frequently monitor their blood glucose levels. Gastrointestinal side effects such as diarrhea, nausea, and vomiting may occur, so it is helpful to take this medication with food initially. In case of allergic reactions, it is important to inform the physician immediately and stop taking the medication. This medication may reduce vitamin B12 levels, so regular monitoring of vitamin B12 status is advisable for long-term users. Blood glucose control should be regularly checked, and kidney function should also be periodically evaluated, as dosage adjustments may be necessary depending on the condition. Overdosage may lead to hypoglycemia or lactic acidosis, so immediate medical attention should be sought for appropriate treatment. If pregnant or planning to become pregnant, or if breastfeeding, this medication should not be used, and appropriate treatment methods should be discussed with a doctor. Care should be taken when driving or operating machinery as hypoglycemia or dizziness may increase the risk of accidents. When storing this medication, keep it out of reach of children and avoid transferring it to other containers.

Side effects

Lactic acidosis, hypoglycemia, diarrhea, nausea, vomiting, abdominal distension, loss of appetite, dyspepsia, constipation, abdominal pain, metallic taste, visual impairment, taste disorder, erythema, itching, hives, thrombocytopenia, leukopenia, hemolytic anemia, anemia, agranulocytosis, pancytopenia, peripheral neuropathy, vitamin B12 deficiency, increased liver enzymes, liver function damage, cholestasis, jaundice, hepatitis, allergic vasculitis, photosensitivity, decreased serum sodium concentration, hypothyroidism, magnesium deficiency during diarrhea, encephalopathy, hair loss, weight gain, palpitations, dizziness, benign prostatic hyperplasia, leg edema, cardiac arrest, rectal adenocarcinoma, lightheadedness, liver dysfunction, arthralgia, facial edema, erectile dysfunction, facial flushing, gastritis, symptoms of hypoglycemia (headache, severe hunger, fatigue, sleepiness, weakness, drowsiness, sleep disturbances, instability, aggression, attention deficit, concentration impairment, abnormal reactions, depression, confusion, aphasia, language loss, visual disturbances, tremors, paralysis, sensory disorders, inability to self-regulate, delirium, cerebral seizures, loss of consciousness, coma, weak breathing, slow heartbeat, sweating, clammy skin, anxiety, rapid heartbeat, hypertension, palpitations, angina, deep vein thrombosis, stroke-like symptoms, pancreatitis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container that prevents air and moisture from entering. It is best to avoid extremes of temperature, storing it at room temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

White oblong film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.